{"id":"https://openalex.org/W855417439","doi":null,"title":"Gene expression profiling from blood for early detection of breast cancer","display_name":"Gene expression profiling from blood for early detection of breast cancer","publication_year":2006,"publication_date":"2006-04-15","ids":{"openalex":"https://openalex.org/W855417439","mag":"855417439"},"language":"en","primary_location":{"id":"mag:855417439","doi":null,"is_oa":false,"landing_page_url":"https://cancerres.aacrjournals.org/content/66/8_Supplement/846.1","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Cancer Research","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100973250","display_name":"Alexander Krause","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090597","display_name":"Institut Salah-Aza\u00efz","ror":"https://ror.org/00brjxm92","country_code":"TN","type":"healthcare","lineage":["https://openalex.org/I4210090597"]},{"id":"https://openalex.org/I4210139047","display_name":"bioM\u00e9rieux (France)","ror":"https://ror.org/03hf69k85","country_code":"FR","type":"company","lineage":["https://openalex.org/I1284886586","https://openalex.org/I4210139047"]}],"countries":["FR","TN"],"is_corresponding":false,"raw_author_name":"Alexander Krause","raw_affiliation_strings":["bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia","institution_ids":["https://openalex.org/I4210090597","https://openalex.org/I4210139047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019958940","display_name":"Laurent P. Bracco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090597","display_name":"Institut Salah-Aza\u00efz","ror":"https://ror.org/00brjxm92","country_code":"TN","type":"healthcare","lineage":["https://openalex.org/I4210090597"]},{"id":"https://openalex.org/I4210139047","display_name":"bioM\u00e9rieux (France)","ror":"https://ror.org/03hf69k85","country_code":"FR","type":"company","lineage":["https://openalex.org/I1284886586","https://openalex.org/I4210139047"]}],"countries":["FR","TN"],"is_corresponding":false,"raw_author_name":"Laurent Bracco","raw_affiliation_strings":["bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia","institution_ids":["https://openalex.org/I4210090597","https://openalex.org/I4210139047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000815323","display_name":"Jonathan Kearsey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090597","display_name":"Institut Salah-Aza\u00efz","ror":"https://ror.org/00brjxm92","country_code":"TN","type":"healthcare","lineage":["https://openalex.org/I4210090597"]},{"id":"https://openalex.org/I4210139047","display_name":"bioM\u00e9rieux (France)","ror":"https://ror.org/03hf69k85","country_code":"FR","type":"company","lineage":["https://openalex.org/I1284886586","https://openalex.org/I4210139047"]}],"countries":["FR","TN"],"is_corresponding":false,"raw_author_name":"Jonathan Kearsey","raw_affiliation_strings":["bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia","institution_ids":["https://openalex.org/I4210090597","https://openalex.org/I4210139047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025655056","display_name":"Malick Paye","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090597","display_name":"Institut Salah-Aza\u00efz","ror":"https://ror.org/00brjxm92","country_code":"TN","type":"healthcare","lineage":["https://openalex.org/I4210090597"]},{"id":"https://openalex.org/I4210139047","display_name":"bioM\u00e9rieux (France)","ror":"https://ror.org/03hf69k85","country_code":"FR","type":"company","lineage":["https://openalex.org/I1284886586","https://openalex.org/I4210139047"]}],"countries":["FR","TN"],"is_corresponding":false,"raw_author_name":"Malick Paye","raw_affiliation_strings":["bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia","institution_ids":["https://openalex.org/I4210090597","https://openalex.org/I4210139047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070341437","display_name":"Anne-Kim Isnard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090597","display_name":"Institut Salah-Aza\u00efz","ror":"https://ror.org/00brjxm92","country_code":"TN","type":"healthcare","lineage":["https://openalex.org/I4210090597"]},{"id":"https://openalex.org/I4210139047","display_name":"bioM\u00e9rieux (France)","ror":"https://ror.org/03hf69k85","country_code":"FR","type":"company","lineage":["https://openalex.org/I1284886586","https://openalex.org/I4210139047"]}],"countries":["FR","TN"],"is_corresponding":false,"raw_author_name":"Anne-Kim Isnard","raw_affiliation_strings":["bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia","institution_ids":["https://openalex.org/I4210090597","https://openalex.org/I4210139047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038932824","display_name":"V\u00e9ronique Barbalat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090597","display_name":"Institut Salah-Aza\u00efz","ror":"https://ror.org/00brjxm92","country_code":"TN","type":"healthcare","lineage":["https://openalex.org/I4210090597"]},{"id":"https://openalex.org/I4210139047","display_name":"bioM\u00e9rieux (France)","ror":"https://ror.org/03hf69k85","country_code":"FR","type":"company","lineage":["https://openalex.org/I1284886586","https://openalex.org/I4210139047"]}],"countries":["FR","TN"],"is_corresponding":false,"raw_author_name":"V\u00e9ronique Barbalat","raw_affiliation_strings":["bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia","institution_ids":["https://openalex.org/I4210090597","https://openalex.org/I4210139047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024235756","display_name":"Christelle Compagnon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090597","display_name":"Institut Salah-Aza\u00efz","ror":"https://ror.org/00brjxm92","country_code":"TN","type":"healthcare","lineage":["https://openalex.org/I4210090597"]},{"id":"https://openalex.org/I4210139047","display_name":"bioM\u00e9rieux (France)","ror":"https://ror.org/03hf69k85","country_code":"FR","type":"company","lineage":["https://openalex.org/I1284886586","https://openalex.org/I4210139047"]}],"countries":["FR","TN"],"is_corresponding":false,"raw_author_name":"Christelle Compagnon","raw_affiliation_strings":["bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia","institution_ids":["https://openalex.org/I4210090597","https://openalex.org/I4210139047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075380242","display_name":"Bernard Miramand","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090597","display_name":"Institut Salah-Aza\u00efz","ror":"https://ror.org/00brjxm92","country_code":"TN","type":"healthcare","lineage":["https://openalex.org/I4210090597"]},{"id":"https://openalex.org/I4210139047","display_name":"bioM\u00e9rieux (France)","ror":"https://ror.org/03hf69k85","country_code":"FR","type":"company","lineage":["https://openalex.org/I1284886586","https://openalex.org/I4210139047"]}],"countries":["FR","TN"],"is_corresponding":false,"raw_author_name":"Bernard Miramand","raw_affiliation_strings":["bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia","institution_ids":["https://openalex.org/I4210090597","https://openalex.org/I4210139047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111634771","display_name":"Daniel Serin","orcid":"https://orcid.org/0000-0002-9343-4793","observed_orcids":["https://orcid.org/0000-0002-9343-4793"]},"institutions":[{"id":"https://openalex.org/I4210090597","display_name":"Institut Salah-Aza\u00efz","ror":"https://ror.org/00brjxm92","country_code":"TN","type":"healthcare","lineage":["https://openalex.org/I4210090597"]},{"id":"https://openalex.org/I4210139047","display_name":"bioM\u00e9rieux (France)","ror":"https://ror.org/03hf69k85","country_code":"FR","type":"company","lineage":["https://openalex.org/I1284886586","https://openalex.org/I4210139047"]}],"countries":["FR","TN"],"is_corresponding":false,"raw_author_name":"Daniel Serin","raw_affiliation_strings":["bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia"],"raw_orcid":"https://orcid.org/0000-0002-9343-4793","affiliations":[{"raw_affiliation_string":"bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia","institution_ids":["https://openalex.org/I4210090597","https://openalex.org/I4210139047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108653636","display_name":"Farhat Ben Ayed","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090597","display_name":"Institut Salah-Aza\u00efz","ror":"https://ror.org/00brjxm92","country_code":"TN","type":"healthcare","lineage":["https://openalex.org/I4210090597"]},{"id":"https://openalex.org/I4210139047","display_name":"bioM\u00e9rieux (France)","ror":"https://ror.org/03hf69k85","country_code":"FR","type":"company","lineage":["https://openalex.org/I1284886586","https://openalex.org/I4210139047"]}],"countries":["FR","TN"],"is_corresponding":false,"raw_author_name":"Farhat Ben Ayed","raw_affiliation_strings":["bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia","institution_ids":["https://openalex.org/I4210090597","https://openalex.org/I4210139047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069539916","display_name":"Laurent Mineur","orcid":"https://orcid.org/0000-0003-4615-4358","observed_orcids":["https://orcid.org/0000-0003-4615-4358"]},"institutions":[{"id":"https://openalex.org/I4210090597","display_name":"Institut Salah-Aza\u00efz","ror":"https://ror.org/00brjxm92","country_code":"TN","type":"healthcare","lineage":["https://openalex.org/I4210090597"]},{"id":"https://openalex.org/I4210139047","display_name":"bioM\u00e9rieux (France)","ror":"https://ror.org/03hf69k85","country_code":"FR","type":"company","lineage":["https://openalex.org/I1284886586","https://openalex.org/I4210139047"]}],"countries":["FR","TN"],"is_corresponding":false,"raw_author_name":"Laurent Mineur","raw_affiliation_strings":["bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia"],"raw_orcid":"https://orcid.org/0000-0003-4615-4358","affiliations":[{"raw_affiliation_string":"bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia","institution_ids":["https://openalex.org/I4210090597","https://openalex.org/I4210139047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016746462","display_name":"Philippe Leissner","orcid":"https://orcid.org/0000-0001-7503-2873","observed_orcids":["https://orcid.org/0000-0001-7503-2873"]},"institutions":[{"id":"https://openalex.org/I4210090597","display_name":"Institut Salah-Aza\u00efz","ror":"https://ror.org/00brjxm92","country_code":"TN","type":"healthcare","lineage":["https://openalex.org/I4210090597"]},{"id":"https://openalex.org/I4210139047","display_name":"bioM\u00e9rieux (France)","ror":"https://ror.org/03hf69k85","country_code":"FR","type":"company","lineage":["https://openalex.org/I1284886586","https://openalex.org/I4210139047"]}],"countries":["FR","TN"],"is_corresponding":false,"raw_author_name":"Philippe Leissner","raw_affiliation_strings":["bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia"],"raw_orcid":"https://orcid.org/0000-0001-7503-2873","affiliations":[{"raw_affiliation_string":"bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia","institution_ids":["https://openalex.org/I4210090597","https://openalex.org/I4210139047"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109104203","display_name":"Bruno Mougin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090597","display_name":"Institut Salah-Aza\u00efz","ror":"https://ror.org/00brjxm92","country_code":"TN","type":"healthcare","lineage":["https://openalex.org/I4210090597"]},{"id":"https://openalex.org/I4210139047","display_name":"bioM\u00e9rieux (France)","ror":"https://ror.org/03hf69k85","country_code":"FR","type":"company","lineage":["https://openalex.org/I1284886586","https://openalex.org/I4210139047"]}],"countries":["FR","TN"],"is_corresponding":false,"raw_author_name":"Bruno Mougin","raw_affiliation_strings":["bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"bioM\u00e9rieux SA, Grenoble, France, ExonHit Therapeutics, Paris, France, Polyclinique Urbain V, Avignon, France, Clinique Ste Catherine, Avignon, France, Institut Salah Azaiz, Tunis, Tunisia","institution_ids":["https://openalex.org/I4210090597","https://openalex.org/I4210139047"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.04681151,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"66","issue":null,"first_page":"846","last_page":"846"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10885","display_name":"Gene expression and cancer classification","score":0.7285000085830688,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10885","display_name":"Gene expression and cancer classification","score":0.7285000085830688,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.23690000176429749,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.01590000092983246,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9139999747276306},{"id":"https://openalex.org/keywords/early-detection","display_name":"early detection","score":0.9860000014305115},{"id":"https://openalex.org/keywords/circulating-tumor-cells","display_name":"circulating tumor cells","score":0.6880000233650208},{"id":"https://openalex.org/keywords/alternative-splicing","display_name":"alternative splicing","score":0.8790000081062317},{"id":"https://openalex.org/keywords/differential-gene-expression","display_name":"differential gene expression","score":0.5830000042915344},{"id":"https://openalex.org/keywords/diagnostic-biomarkers","display_name":"diagnostic biomarkers","score":0.6539999842643738},{"id":"https://openalex.org/keywords/whole-blood","display_name":"whole blood","score":0.4429999887943268},{"id":"https://openalex.org/keywords/mammography-limitations","display_name":"mammography limitations","score":0.6010000109672546},{"id":"https://openalex.org/keywords/benign-breast-disease","display_name":"benign breast disease","score":0.4950000047683716}],"concepts":[{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.8516131639480591},{"id":"https://openalex.org/C18431079","wikidata":"https://www.wikidata.org/wiki/Q1502169","display_name":"Gene expression profiling","level":4,"score":0.5810985565185547},{"id":"https://openalex.org/C2780472235","wikidata":"https://www.wikidata.org/wiki/Q324634","display_name":"Mammography","level":4,"score":0.5158869028091431},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5000839233398438},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49956321716308594},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.49648648500442505},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.4320739507675171},{"id":"https://openalex.org/C194583182","wikidata":"https://www.wikidata.org/wiki/Q21114084","display_name":"Alternative splicing","level":4,"score":0.4197778105735779},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37644827365875244},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.37586864829063416},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.3311022222042084},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.30214613676071167},{"id":"https://openalex.org/C105580179","wikidata":"https://www.wikidata.org/wiki/Q188928","display_name":"Messenger RNA","level":3,"score":0.22275331616401672},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.14755025506019592},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:855417439","doi":null,"is_oa":false,"landing_page_url":"https://cancerres.aacrjournals.org/content/66/8_Supplement/846.1","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Cancer Research","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8500000238418579}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2128173047","https://openalex.org/W3010423561","https://openalex.org/W7096393740","https://openalex.org/W2128432722","https://openalex.org/W1171267813","https://openalex.org/W2613952279","https://openalex.org/W1665344279","https://openalex.org/W2274377404","https://openalex.org/W2469473819","https://openalex.org/W2078868395"],"abstract_inverted_index":{"Proc":[0],"Amer":[1],"Assoc":[2],"Cancer":[3],"Res,":[4],"Volume":[5],"47,":[6],"2006\n\n3603":[7],"\n\nIt":[8],"is":[9,33,63,278],"now":[10],"well":[11],"established":[12],"that":[13,123,259,326,350],"early":[14,134,216,255,336],"detection":[15,337],"of":[16,26,60,90,105,113,116,130,152,163,205,210,229,234,271,274,285,292,304,314,338,344,346],"breast":[17,40,69,84,136,168,218,236,297,319,339],"cancer":[18,41,137,169,305,340],"improves":[19],"survival":[20],"rates":[21],"and":[22,62,118,133,166,178,194,232,349],"increases":[23],"the":[24,34,88,111,128,150,181,188,203,225,230,235,272,275,312,315,335,342],"probability":[25],"successful":[27],"treatment.":[28],"To":[29],"date,":[30],"mammographic":[31],"screening":[32,83],"most":[35,189],"reliable":[36],"method":[37,81,223],"to":[38,53,65,77,186,202,224,310,359],"detect":[39,54],"in":[42,58,70,94,184,263,308],"asymptomatic":[43],"women.":[44,72],"However,":[45],"mammography":[46],"has":[47,144],"significant":[48,190],"limitations:":[49],"it":[50],"often":[51],"fails":[52],"very":[55,357],"small":[56],"tumors":[57],"absence":[59],"microcalcifications":[61],"difficult":[64],"interpret":[66],"with":[67,107,245],"dense":[68],"young":[71],"These":[73],"limitations":[74],"lead":[75],"us":[76],"evaluate":[78,311],"an":[79],"alternative":[80],"for":[82,149,318,334],"cancers":[85,237],"based":[86],"on":[87,180,355],"identification":[89,204],"a":[91,114,206,281,327],"molecular":[92],"signature":[93,208,277,317],"peripheral":[95],"blood":[96,129,161,248,264,290,348],"cells.":[97,365],"ExonHit\u2019s":[98],"gene":[99,316,328],"profiling":[100],"technology":[101],"DATAS":[102,154],"(Differential":[103],"Analysis":[104],"Transcripts":[106],"Alternative":[108],"Splicing)":[109],"allowed":[110],"isolation":[112],"set":[115,147],"messengers":[117],"alternatively":[119],"spliced":[120],"mRNA":[121],"sequences":[122],"were":[124,175,238],"differentially":[125],"expressed":[126,361],"between":[127],"healthy":[131,213,251],"women":[132,214],"stage":[135,170,217],"patients.":[138,287],"A":[139,241],"customised":[140],"Affymetrix":[141],"Genechip":[142],"array":[143,183],"then":[145],"been":[146,198],"up":[148],"validation":[151,244],"those":[153],"clones.":[155],"Total":[156],"RNA":[157],"extracted":[158],"from":[159,215,295,362],"whole":[160,347],"samples":[162,249,291],"37":[164],"controls":[165,231,252],"55":[167],"I/II":[171],"(i.e.":[172],"train":[173,226],"group)":[174],"amplified,":[176],"labeled":[177],"hybridized":[179],"custom":[182],"order":[185,309],"identify":[187],"diagnostic":[191,267],"markers.":[192],"Monoparametric":[193],"multiparametric":[195],"approaches":[196],"have":[197],"carried":[199],"out,":[200],"leading":[201],"54-gene":[207],"capable":[209],"clearly":[211],"distinguishing":[212],"cancers.":[219],"By":[220],"applying":[221],"this":[222,260],"group,":[227],"86.5%":[228],"92.7%":[233],"correctly":[239],"classified.":[240],"first,":[242],"limited":[243],"21":[246],"independent":[247,283],"(5":[250],"vs":[253],"16":[254],"stage-breast":[256],"cancers)":[257],"showed":[258],"expression":[261],"profile":[262],"kept":[265],"its":[266],"power.":[268],"The":[269],"confirmation":[270],"robustness":[273],"blood-molecular":[276],"underway":[279],"using":[280],"larger":[282],"cohort":[284],"1000":[286],"In":[288],"parallel,":[289],"patients":[293],"suffering":[294],"benign":[296],"diseases,":[298],"inflammatory":[299],"diseases":[300],"or":[301],"other":[302],"types":[303],"are":[306],"processed":[307],"specificity":[313],"cancer.":[320],"Taken":[321],"together,":[322],"our":[323],"results":[324],"show":[325],"expression-based":[329],"assay":[330,352],"can":[331],"be":[332,360],"developed":[333],"through":[341],"use":[343],"5ml":[345],"such":[351],"will":[353],"rely":[354],"transcripts":[356],"unlikely":[358],"circulating":[363],"tumor":[364]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2016-06-24T00:00:00"}